The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Rocket Pharmaceuticals Inc. (RCKT) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.22, or 0.91%, to $24.27. The Rocket Pharmaceuticals Inc. has recorded 56,277 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that Rocket Pharmaceuticals Announces Pricing of Public Offering of Common Stock.
Rocket Pharmaceuticals Inc. is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $24.05 and fluctuated between $24.65 as its day high and $20.22 as its day low. The current market capitalization of Rocket Pharmaceuticals Inc. is $1.97B. A total of 7.54 million shares were traded on the day, compared to an average of 969.57K shares.
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, RCKT has seen 1 BUY and 3 SELL insider trades, representing the acquisition of 1,586 and the disposition of 2,391 shares. Over the last 12 months, there were 12 BUYs and 10 SELLs from insiders. Insiders purchased 2,040,867 shares during that period but sold 27,425.
In the most recent transaction, Shah Gaurav sold 4,767 shares of RCKT for 15.47 per share on Aug 17. After the transaction, the CEO now owns 524,854 company shares. In a previous transaction on Aug 17, Patel Kinnari sold 1,534 shares at 15.47 per share. RCKT shares that owns now total 216,448.
Among the insiders who sold shares, Militello John disposed of 284 shares on Aug 17 at a per-share price of $15.47. This resulted in the insider holding 5,570 shares of RCKT after the transaction. In another insider transaction, Militello John sold 573 shares at $19.03 per share on Jul 20. Company shares held by the insider now total 7,129.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for RCKT in the last 3 months, the mean price target is $50.67 with high estimates of $65.00 and low estimates of $39.00. In terms of 52-week highs and lows, RCKT has a high of $24.53 and a low of $11.78.
As of this writing, RCKT has an earnings estimate of -$0.81 per share for the current quarter. EPS was calculated based on a consensus of 11 estimates, with a high estimate of -$0.65 per share and a lower estimate of -$0.93. The company reported an EPS of -$0.73 in the last quarter, which was 14.10% higher than expectations of -$0.85.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. RCKT’s latest balance sheet shows that the firm has $388.74M in Cash & Short Term Investments as of fiscal 2021. There were $22.60M in debt and $22.17M in liabilities at the time. Its Book Value Per Share was $5.01, while its Total Shareholder’s Equity was $454.72M.
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RCKT is Buy with a score of 4.92.